Literature DB >> 34288999

Molecular probes for selective detection of cysteine cathepsins.

Kelton A Schleyer1, Lina Cui1.   

Abstract

Cysteine cathepsins are proteases critical in physiopathological processes and show potential as targets or biomarkers for diseases and medical conditions. The 11 members of the cathepsin family are redundant in some cases but remarkably independent of others, demanding the development of both pan-cathepsin targeting tools as well as probes that are selective for specific cathepsins with little off-target activity. This review addresses the diverse design strategies that have been employed to accomplish this tailored selectivity among cysteine cathepsin targets and the imaging modalities incorporated. The power of these diverse tools is contextualized by briefly highlighting the nature of a few prominent cysteine cathepsins, their involvement in select diseases, and the application of cathepsin imaging probes in research spanning basic biochemical studies to clinical applications.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34288999      PMCID: PMC8295534          DOI: 10.1039/d1ob00225b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.890


  217 in total

1.  Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment.

Authors:  Alexei A Bogdanov; Charles P Lin; Maria Simonova; Lars Matuszewski; Ralph Weissleder
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Fluorescent peptide probes for in vivo diagnostic imaging.

Authors:  Ching-Hsuan Tung
Journal:  Biopolymers       Date:  2004       Impact factor: 2.505

Review 3.  Fluorescence lifetime measurements and biological imaging.

Authors:  Mikhail Y Berezin; Samuel Achilefu
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Lysosome-Targeting Fluorogenic Probe for Cathepsin B Imaging in Living Cells.

Authors:  Yuqi Wang; Jinbo Li; Liandong Feng; Jingfang Yu; Yan Zhang; Deju Ye; Hong-Yuan Chen
Journal:  Anal Chem       Date:  2016-11-30       Impact factor: 6.986

5.  Fluorescent nitrile-based inhibitors of cysteine cathepsins.

Authors:  Maxim Frizler; Matthias D Mertens; Michael Gütschow
Journal:  Bioorg Med Chem Lett       Date:  2012-10-03       Impact factor: 2.823

6.  Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.

Authors:  T T Lah; M Cercek; A Blejec; J Kos; E Gorodetsky; R Somers; I Daskal
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

7.  Plasma cathepsin L: a prognostic marker for pancreatic cancer.

Authors:  Nidhi Singh; Prasenjit Das; Surabhi Gupta; Vikas Sachdev; Siddhartha Srivasatava; Siddhartha Datta Gupta; Ravindra Mohan Pandey; Peush Sahni; Shyam S Chauhan; Anoop Saraya
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

8.  Design and synthesis of fluorogenic substrate-based probes for detecting Cathepsin B activity.

Authors:  Shusheng Wang; Brady G Vigliarolo; Morshed A Chowdhury; Jennifer N K Nyarko; Darrell D Mousseau; Christopher P Phenix
Journal:  Bioorg Chem       Date:  2019-08-14       Impact factor: 5.275

Review 9.  Cathepsins mediate tumor metastasis.

Authors:  Gong-Jun Tan; Zheng-Ke Peng; Jin-Ping Lu; Fa-Qing Tang
Journal:  World J Biol Chem       Date:  2013-11-26

10.  Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples.

Authors:  Marcin Poreba; Katarzyna Groborz; Matej Vizovisek; Marco Maruggi; Dusan Turk; Boris Turk; Garth Powis; Marcin Drag; Guy S Salvesen
Journal:  Chem Sci       Date:  2019-07-31       Impact factor: 9.825

View more
  2 in total

Review 1.  Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.

Authors:  Daan G J Linders; Okker D Bijlstra; Laura C Fallert; Denise E Hilling; Ethan Walker; Brian Straight; Taryn L March; A Rob P M Valentijn; Martin Pool; Jacobus Burggraaf; James P Basilion; Alexander L Vahrmeijer; Peter J K Kuppen
Journal:  Mol Imaging Biol       Date:  2022-08-24       Impact factor: 3.484

2.  CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.

Authors:  Kaiming Ma; Xin Chen; Weihai Liu; Suhua Chen; Chenlong Yang; Jun Yang
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.